F
FibroBiologics, Inc. (FBLG)
NCM – Real vaqt narxi. Valyuta: USD
1.11
+0.08 (7.77%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.13
+0.02 (2.01%)
Bozordan keyin: Aug 12, 2026, 4:50 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.11
+0.08 (7.77%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.13
+0.02 (2.01%)
Bozordan keyin: Aug 12, 2026, 4:50 PM EDT
FibroBiologics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, surunkali kasalliklardan aziyat chekayotgan bemorlar uchun fibroblastlarga asoslangan terapiyalarni ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniyaning mahsulot quvuri quyidagilarni o'z ichiga oladi: CYWC628, yaralarni davolash uchun preklinik sinovdan o'tgan; CYMS101, ko'p sklerozni davolash uchun 1-bosqich sinovidan o'tgan; CybroCell, degenerativ disk kasalligini davolash uchun; va CYPS317, psoriazni davolash uchun. Shuningdek, u quyidagilarni o'z ichiga olgan dastlabki tadqiqot mahsulotlarini ishlab chiqadi: inson umrini uzaytirishni davolash uchun CYTER915; va ma'lum saraton turlarini davolash uchun TCB190. FibroBiologics, Inc. 2021 yilda tashkil etilgan va shtab-kvartirasi Xyustonda, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Hamid Khoja Ph.D. | Chief Scientific Officer |
| Mr. Jason D. Davis CPA | Chief Financial Officer |
| Mr. Peter O'Heeron | Founder, Chairperson & CEO |
| Mr. Ruben A. Garcia J.D. | General Counsel |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-31 | DEF 14A | fblg-20260731.htm |
| 2026-07-31 | 10-Q | fblg-20260630.htm |
| 2026-07-24 | 8-K | fblg-20260722.htm |
| 2026-07-17 | PRE 14A | fblg-20260717.htm |
| 2026-07-10 | S-3 | fblg-20260709.htm |
| 2026-07-09 | 8-K | fblg-20260702.htm |
| 2026-06-29 | D | |
| 2026-06-23 | 8-K | fblg-20260622.htm |
| 2026-05-06 | 8-K | fblg-20260505.htm |
| 2026-05-05 | DEFA14A | fblg-20260504.htm |